JOSEPH NEWMAN to Anti-Bacterial Agents
This is a "connection" page, showing publications JOSEPH NEWMAN has written about Anti-Bacterial Agents.
Connection Strength
0.803
-
Mass Balance and Drug Interaction Potential of Intravenous Eravacycline Administered to Healthy Subjects. Antimicrob Agents Chemother. 2019 03; 63(3).
Score: 0.265
-
Randomized, Double-Blind, Placebo-Controlled Studies of the Safety and Pharmacokinetics of Single and Multiple Ascending Doses of Eravacycline. Antimicrob Agents Chemother. 2018 11; 62(11).
Score: 0.259
-
The Fluorocycline TP-271 Is Efficacious in Models of Aerosolized Bacillus anthracis Infection in BALB/c Mice and Cynomolgus Macaques. Antimicrob Agents Chemother. 2017 10; 61(10).
Score: 0.060
-
Pyridodiazepine amines are selective therapeutic agents for helicobacter pylori by suppressing growth through inhibition of glutamate racemase but are predicted to require continuous elevated levels in plasma to achieve clinical efficacy. Antimicrob Agents Chemother. 2015 Apr; 59(4):2337-42.
Score: 0.050
-
NBTI 5463 is a novel bacterial type II topoisomerase inhibitor with activity against gram-negative bacteria and in vivo efficacy. Antimicrob Agents Chemother. 2014 May; 58(5):2657-64.
Score: 0.047
-
In vitro pharmacodynamics of AZD5206 against Staphylococcus aureus. Antimicrob Agents Chemother. 2013 Feb; 57(2):1062-4.
Score: 0.043
-
Novel N-linked aminopiperidine inhibitors of bacterial topoisomerase type II with reduced pK(a): antibacterial agents with an improved safety profile. J Med Chem. 2012 Aug 09; 55(15):6916-33.
Score: 0.042
-
Novel bacterial NAD+-dependent DNA ligase inhibitors with broad-spectrum activity and antibacterial efficacy in vivo. Antimicrob Agents Chemother. 2011 Mar; 55(3):1088-96.
Score: 0.038